{"id":596045,"date":"2026-08-17T13:42:11","date_gmt":"2026-08-17T13:42:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/596045\/"},"modified":"2026-08-17T13:42:11","modified_gmt":"2026-08-17T13:42:11","slug":"may-lucie-meyer-etop-ibcsg-position-statement-on-t-cell-engagers-in-sclc","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/596045\/","title":{"rendered":"May-Lucie Meyer: ETOP IBCSG Position Statement on T-Cell Engagers in SCLC"},"content":{"rendered":"<p>May-Lucie Meyer,\u00a0Medical Oncologist at Lausanne University Hospital, shared a post on\u00a0<a href=\"https:\/\/www.linkedin.com\/feed\/update\/urn:li:activity:7494711770410950657\/\" target=\"_blank\" rel=\"noopener nofollow\">LinkedIn<\/a>:<\/p>\n<p>\u201cOne week before our next workshop, I\u2019m pleased to share this publication reporting the latest ETOP IBCSG reflections on TCEs, bringing together a multidisciplinary, cross-disease perspective on this rapidly evolving and promising class of drugs, highlighting both their potential and the key questions that remain for their optimal use in clinical practice.<\/p>\n<p>Looking forward to continuing the discussion at the upcoming workshop!\u201d<\/p>\n<p>\u00a0<\/p>\n<p>Title: T-cell engagers in small-cell lung cancer: current evidence and future directions \u2013 a position statement from the ETOP IBCSG Partners Foundation Workshop<\/p>\n<p>Authors:<\/p>\n<p>Read the <a href=\"https:\/\/www.cancertreatmentreviews.com\/article\/S0305-7372(26)00115-5\/abstract\" target=\"_blank\" rel=\"noopener nofollow\">full article<\/a>.<\/p>\n<p>You can also read: <a href=\"https:\/\/oncodaily.com\/oncolibrary\/lung-oncology\/rezilient3\" rel=\"nofollow noopener\" target=\"_blank\">REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-568322\" src=\"https:\/\/www.newsbeep.com\/ie\/wp-content\/uploads\/2026\/08\/1e9cae66f1399d34f274a14bb3da6675_exif-1-1280x720-1-1-800x450.webp\" alt=\"May-Lucie Meyer: ETOP IBCSG Position Statement on T-Cell Engagers in SCLC\" width=\"800\" height=\"450\" title=\"May-Lucie Meyer: ETOP IBCSG Position Statement on T-Cell Engagers in SCLC 2\"  \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"May-Lucie Meyer,\u00a0Medical Oncologist at Lausanne University Hospital, shared a post on\u00a0LinkedIn: \u201cOne week before our next workshop, I\u2019m&hellip;\n","protected":false},"author":2,"featured_media":596046,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-596045","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/596045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=596045"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/596045\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/596046"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=596045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=596045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=596045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}